Thioredoxin-mimetic peptide attenuates epilepsy progression and neurocognitive deficits
Top Cited Papers
Open Access
- 10 January 2026
- journal article
- Published by Elsevier in Redox Biology
- Vol. 90, 104021
Abstract
No abstract availableKeywords
Funding Information
- Israel Science Foundation (1976 /20)
- Ministry of Science and Technology, Israel
- Ministry of Innovation, Science and Technology (5100)
This publication has 87 references indexed in Scilit:
- Implicating neuroinflammation in hippocampus, prefrontal cortex and amygdala with cognitive deficit: a narrative review3 Biotech, 2025
- TXM peptides inhibit SARS-CoV-2 infection, syncytia formation, and lower inflammatory consequencesAntiviral Research, 2024
- Polystyrene microplastics mediate cell cycle arrest, apoptosis, and autophagy in the G2/M phase through ROS in grass carp kidney cellsEnvironmental Toxicology, 2023
- The thioredoxin system: Balancing redox responses in immune cells and tumorsEuropean Journal of Immunology, 2022
- Treatment Outcomes in Patients With Newly Diagnosed Epilepsy Treated With Established and New Antiepileptic DrugsJAMA Neurology, 2018
- Oxidative Stress Contributes to Status Epilepticus Associated MortalityNeurochemical Research, 2017
- N‐acetylcysteine (NAC) in neurological disorders: mechanisms of action and therapeutic opportunitiesBrain and Behavior, 2014
- Mitochondrial dysfunction and oxidative stress: a contributing link to acquired epilepsy?Journal of Bioenergetics and Biomembranes, 2010
- Antioxidant Therapy in Neurologic DiseaseArchives of Neurology, 2000
- Modification of seizure activity by electrical stimulation: II. Motor seizureElectroencephalography and Clinical Neurophysiology, 1972